On 2025-05-05, Castle Biosciences, Inc. (CSTL) announced earnings per share of $-0.20 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.08.
The next expected annoucement date for quarterly earnings is 2025-08-04, with an average estimated earnings per share of $-0.44 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-05 | 2025-03-31 | $-0.08 | $-0.20 |
| 2025-02-27 | 2024-12-31 | $0.11 | $0.32 |
| 2024-11-04 | 2024-09-30 | $-0.06 | $0.08 |
| 2024-08-05 | 2024-06-30 | $-0.16 | $0.31 |
| 2024-05-02 | 2024-03-31 | $-0.37 | $-0.09 |
| 2024-02-28 | 2023-12-31 | $-0.84 | $-0.10 |
| 2023-11-02 | 2023-09-30 | $-0.92 | $-0.26 |
| 2023-08-02 | 2023-06-30 | $-1.01 | $-0.70 |
| 2023-05-03 | 2023-03-31 | $-0.80 | $-1.10 |
| 2023-02-28 | 2022-12-31 | $-0.91 | $-0.78 |
| 2022-11-02 | 2022-09-30 | $-0.70 | $-0.77 |
| 2022-08-08 | 2022-06-30 | $-0.58 | $-0.06 |
| 2022-05-09 | 2022-03-31 | $-0.67 | $-0.80 |
| 2022-02-28 | 2021-12-31 | $-0.43 | $-0.25 |
| 2021-11-08 | 2021-09-30 | $-0.35 | $-0.47 |
| 2021-08-09 | 2021-06-30 | $-0.29 | $-0.34 |
| 2021-05-10 | 2021-03-31 | $-0.22 | $-0.17 |
| 2021-03-08 | 2020-12-31 | $-0.11 | $-0.16 |
| 2020-11-09 | 2020-09-30 | $-0.06 | $-0.23 |
| 2020-08-10 | 2020-06-30 | $-0.42 | $-0.08 |
| 2020-05-11 | 2020-03-31 | $-0.12 | $0.03 |
| 2020-03-10 | 2019-12-31 | $-0.20 | $0.11 |
| 2019-11-11 | 2019-09-30 | $-0.31 | $-0.31 |
| 2019-09-03 | 2019-06-30 | $-0.52 | $-1.05 |